Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium
- PMID: 12962945
- DOI: 10.1016/s0029-7844(03)00618-5
Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium
Abstract
Objective: To determine whether use of steroid hormone contraceptives modifies immune defense parameters of the vaginal epithelium in humans.
Methods: Vaginal biopsies were collected during the follicular and luteal phases in regularly menstruating women (controls) and in women using combined oral contraceptives, depot-medroxyprogesterone acetate injections, or levonorgestrel implants. Fifteen healthy women (aged 20-34 years) were enrolled in each group. Biopsies were analyzed in a blinded manner. Epithelial thickness was estimated by morphometry. Immune cells were analyzed by immunomorphometry with cell-type-specific monoclonal antibodies.
Results: The epithelium of controls harbored 241+/-35 leukocytes (CD45+ cells) per mm2 (mean+/-1 standard error of the mean), and the thickness was 261+/-16 microm. T lymphocytes (CD3+) dominated, and cytotoxic or suppressor T cells (CD8+) were more frequent than T helper cells (CD4:CD8 ratio: 0.7+/- 0.1). Macrophages (CD68+) constituted the second-largest population, followed by Langerhans cells (CD1a+). B cells, natural killer cells, monocytes, and granulocytes were generally absent. There were no significant differences between the follicular and luteal phases. The epithelium was significantly thicker in all three groups that used hormonal contraceptive (333+/-9 microm) compared with controls, and it exhibited superficial hyperplasia. The frequency of intraepithelial leukocytes (CD45+) was increased in depot-medroxyprogesterone acetate (P<.001) and levonorgestrel implant users (P<.04). In depot-medroxyprogesterone acetate users, this was explained by an increased frequency of the CD8+ T lymphocyte subset.
Conclusion: Hormonal contraceptives induce hyperplasia of the vaginal epithelium. The significant changes in the intraepithelial leukocyte population in depot-medroxyprogesterone acetate and levonorgestrel implant users most probably reflect altered local immune capacity.
Similar articles
-
Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.AIDS Res Hum Retroviruses. 2013 Mar;29(3):592-601. doi: 10.1089/aid.2012.0271. Epub 2012 Nov 28. AIDS Res Hum Retroviruses. 2013. PMID: 23189932 Free PMC article.
-
Steroid receptor expression in vaginal epithelium of healthy fertile women and influences of hormonal contraceptive usage.Contraception. 2005 Nov;72(5):383-92. doi: 10.1016/j.contraception.2005.05.018. Epub 2005 Aug 9. Contraception. 2005. PMID: 16246667
-
Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.Am J Reprod Immunol. 2018 Oct;80(4):e13029. doi: 10.1111/aji.13029. Epub 2018 Aug 3. Am J Reprod Immunol. 2018. PMID: 30076667
-
New knowledge in the physiology of hormonal contraceptives.Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1499-507. doi: 10.1016/s0002-9378(94)05011-8. Am J Obstet Gynecol. 1994. PMID: 8178898 Review.
-
Menstrual impact of contraception.Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1513-22. doi: 10.1016/s0002-9378(94)05013-1. Am J Obstet Gynecol. 1994. PMID: 8178900 Review.
Cited by
-
Evaluating the impact of three progestin-based hormonal contraceptive methods on immunologic changes in the female genital tract and systemically (CHIME Study): a prospective cohort study protocol.BMC Womens Health. 2022 Nov 18;22(1):456. doi: 10.1186/s12905-022-02053-w. BMC Womens Health. 2022. PMID: 36401326 Free PMC article.
-
Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.PLoS One. 2020 Mar 26;15(3):e0230473. doi: 10.1371/journal.pone.0230473. eCollection 2020. PLoS One. 2020. PMID: 32214321 Free PMC article. Clinical Trial.
-
Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.Mucosal Immunol. 2017 Sep;10(5):1097-1107. doi: 10.1038/mi.2017.35. Epub 2017 Apr 12. Mucosal Immunol. 2017. PMID: 28401937 Review.
-
Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.Int J Womens Health. 2013 Oct 21;5:695-708. doi: 10.2147/IJWH.S34030. Int J Womens Health. 2013. PMID: 24174884 Free PMC article. Review.
-
Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive.J Reprod Immunol. 2015 Aug;110:14-21. doi: 10.1016/j.jri.2015.03.007. Epub 2015 Apr 22. J Reprod Immunol. 2015. PMID: 25956139 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous